This narrative critique describes an overview of the many effects of methylphenidate (MPH) in attention-deficit/hyperactivity dysfunction (ADHD) and its opportunity neurobiological targets. It tackled the next facets: one) MPH effects on attention and government features in ADHD; 2) the relation involving MPH efficacy and dopamine transporter gene